the continuing success story of immunotherapy in nsclc
Published 1 year ago • 1.5K plays • Length 1:27:28Download video MP4
Download video MP3
Similar videos
-
1:44:45
gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
1:09:47
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:10:25
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
51:59
facilitating progress in the treatment of sclc
-
53:19
improving survival and cure rates in resectable nsclc with perioperative immunotherapy
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:31:04
immunotherapy for sclc and the "four ps" in managed care—patient, provider, pharmacy, and plan
-
1:11:21
maximizing the potential of immunotherapy in unresectable stage iii nsclc
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
3:29
faith and an immunotherapy clinical trial: barry's lung cancer story
-
39:06
unleashing the potential of perioperative immunotherapy in resectable nsclc
-
1:11:16
immunotherapy as a game-changer in multimodal management of lung cancer
-
43:46
realizing the promise of perioperative immunotherapy in resectable nsclc
-
1:10:20
watch drs broderick & wakelee discuss the latest in nsclc: https://bit.ly/2021-nsclc